Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

Clicks: 219
ID: 265789
1997
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Sch 56592 is a new triazole agent with potent, broad-spectrum antifungal activity. The in vitro activities of Sch 56592, itraconazole, fluconazole, amphotericin B, and flucytosine (5-FC) against 404 clinical isolates of Candida spp. (382 isolates) and Saccharomyces cerevisiae (22 isolates) were inve ā€¦
Reference Key
ma1997antimicrobialactivity Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pfaller MA;Messer S;Jones RN;;
Journal Antimicrobial agents and chemotherapy
Year 1997
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9021172
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Comparative Study microbial sensitivity tests r n jones m a pfaller antifungal agents / pharmacology* candida / drug effects* triazoles / pharmacology* candida / isolation & purification saccharomyces cerevisiae / isolation & purification pmid:9021172 pmc163694 doi:10.1128/aac.41.2.233 s messer amphotericin b / pharmacology fluconazole / pharmacology flucytosine / pharmacology itraconazole / pharmacology saccharomyces cerevisiae / drug effects*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.